197 related articles for article (PubMed ID: 11975823)
1. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: focus on beta-adrenergic blockade.
Frishman WH; Kowalski M; Nagnur S; Warshafsky S; Sica D
Heart Dis; 2001; 3(6):386-97. PubMed ID: 11975823
[TBL] [Abstract][Full Text] [Related]
2. Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Frishman WH; Fuksbrumer MS; Tannenbaum M
J Clin Pharmacol; 1994 Aug; 34(8):795-803. PubMed ID: 7962666
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension.
Han JA; Frishman WH; Wu Sun S; Palmiero PM; Petrillo R
Cardiol Rev; 2008; 16(2):95-108. PubMed ID: 18281912
[TBL] [Abstract][Full Text] [Related]
4. The safety of topical beta-blockers in glaucoma treatment.
Goldberg I
Med J Aust; 1996 Apr; 164(8):498-9. PubMed ID: 8614346
[TBL] [Abstract][Full Text] [Related]
5. Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.
Brooks AM; Gillies WE
Drugs Aging; 1992; 2(3):208-21. PubMed ID: 1351412
[TBL] [Abstract][Full Text] [Related]
6. Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Diggory P; Cassels-Brown A; Fernandez C
Age Ageing; 1996 Nov; 25(6):424-8. PubMed ID: 9003876
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
Netland PA; Weiss HS; Stewart WC; Cohen JS; Nussbaum LL
Am J Ophthalmol; 1997 Apr; 123(4):465-77. PubMed ID: 9124243
[TBL] [Abstract][Full Text] [Related]
8. Topical ophthalmic beta blockers: a comparative review.
Zimmerman TJ
J Ocul Pharmacol; 1993; 9(4):373-84. PubMed ID: 7906296
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of 0.5% timolol maleate ophthalmic gel-forming solution QD compared with 0.5% levobunolol hydrochloride BID in patients with open-angle glaucoma or ocular hypertension.
Walters TR; Maloney S; Slater D; Liss C; Wilson H; Hartenbaum D
Clin Ther; 1998; 20(6):1170-8. PubMed ID: 9916610
[TBL] [Abstract][Full Text] [Related]
10. The potential systemic effect of topically applied beta-blockers in glaucoma therapy.
Taniguchi T; Kitazawa Y
Curr Opin Ophthalmol; 1997 Apr; 8(2):55-8. PubMed ID: 10168358
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects.
Mirza GE; Karaküçük S; Temel E
J Glaucoma; 2000 Feb; 9(1):45-50. PubMed ID: 10708231
[TBL] [Abstract][Full Text] [Related]
12. New topical beta-blockers for glaucoma.
Drug Ther Bull; 1987 Aug; 25(16):63-4. PubMed ID: 2887414
[No Abstract] [Full Text] [Related]
13. Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension.
Henness S; Swainston Harrison T; Keating GM
Drugs Aging; 2007; 24(6):509-28. PubMed ID: 17571916
[TBL] [Abstract][Full Text] [Related]
14. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
[TBL] [Abstract][Full Text] [Related]
15. Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.
Le Jeunne CL; Hugues FC; Dufier JL; Munera Y; Bringer L
J Clin Pharmacol; 1989 Feb; 29(2):97-101. PubMed ID: 2565918
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the ocular beta-blockers.
Sorensen SJ; Abel SR
Ann Pharmacother; 1996 Jan; 30(1):43-54. PubMed ID: 8773166
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ophthalmic beta-blocking agents.
Lesar TS
Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial of MK-507, Trusopt, for raised intraocular pressure--the Australian experience.
Gillies WE; Brooks AM
Aust N Z J Ophthalmol; 1996 May; 24(2):111-5. PubMed ID: 9199740
[TBL] [Abstract][Full Text] [Related]
19. Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension.
Battershill PE; Sorkin EM
Drugs; 1988 Nov; 36(5):601-15. PubMed ID: 2905641
[TBL] [Abstract][Full Text] [Related]
20. Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
Stewart WC; Dubiner HB; Mundorf TK; Laibovitz RA; Sall KN; Katz LJ; Singh K; Shulman DG; Siegel LI; Hudgins AC; Nussbaum L; Apostolaros M
Am J Ophthalmol; 1999 Feb; 127(2):142-7. PubMed ID: 10030554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
